1-3 of 3
Keywords: Abiraterone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

Available to Purchase
Subject Area:
Further Areas
Wan-Yun Fang, Pai-Fu Wang, Yen-Chun Fan, Hung-Jen Shih
Journal: Urologia Internationalis
Urol Int (2021) 105 (5-6): 380–385.
https://doi.org/10.1159/000509882
Published Online: 13 August 2020
... included postdocetaxel patients with mCRPC treated with abiraterone acetate combined with prednisone (AA + P) who had experienced prostate-specific antigen (PSA) progression. All patients underwent a steroid switch from prednisone (10 mg/day) to dexamethasone (1 mg/day). The PSA level and clinical symptoms...
View article titled, Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
Open the PDF for Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate in another window
Journal Articles

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

Available to Purchase
Subject Area:
Further Areas
Holger Hans Herman Erb, Peter Sparwasser, Tamara Diehl, Manuela Hemmerlein-Thomas, Igor Tsaur, Eva Jüngel, Ulrich Sommer, Gustavo B. Baretton, Axel Haferkamp, Andreas Neisius, Christian Thomas
Journal: Urologia Internationalis
Urol Int (2020) 104 (3-4): 253–262.
https://doi.org/10.1159/000504416
Published Online: 17 January 2020
... = 26) before, while, and after undergoing a new therapy with chemotherapy (cabazitaxel or docetaxel) or antiandrogen (enzalutamide or abiraterone). CTCs were sequentially cytospun on object slides, and AR-V7 status was then detected by IHC based on a staining regime established on a 22Rv1 cell line...
View article titled, AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC
Open the PDF for AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC in another window
Journal Articles

Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells

Available to Purchase
Subject Area:
Further Areas
Martin Weiss, Hannes Ahrend, Hannah Grossebrummel, Patrick Ziegler, Lars-Ove Brandenburg, Reinhard Walther, Uwe Zimmermann, Martin Burchardt, Matthias B. Stope
Journal: Urologia Internationalis
Urol Int (2016) 97 (1): 112–117.
https://doi.org/10.1159/000445251
Published Online: 24 March 2016
...Martin Weiss; Hannes Ahrend; Hannah Grossebrummel; Patrick Ziegler; Lars-Ove Brandenburg; Reinhard Walther; Uwe Zimmermann; Martin Burchardt; Matthias B. Stope Introduction: Inhibition of androgen synthesis by abiraterone acetate (AA) entails enhanced overall survival rates and clinical benefit...
View article titled, Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells
Open the PDF for Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells in another window